Binfeng Lu

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Systemic Lupus Erythematosus

Papillary Thyroid

Top Venues

Cancer immunology research

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Han Zhang, Sanghoon Lee, Renee R Muthakana, Binfeng Lu, David N Boone, Daniel Lee, Xiao-Song Wang
Intragenic Rearrangement Burden Associates with Immune Cell Infiltration and Response to Immune Checkpoint Blockade in Cancer. Cancer immunology research 12 (3) (2024)
Han Zhang, Sanghoon Lee, Renee R Muthakana, Binfeng Lu, David N Boone, Daniel Lee, Xiao-Song Wang
Intragenic Rearrangement Burden Associates with Immune Cell Infiltration and Response to Immune Checkpoint Blockade in Cancer. Cancer immunology research 12 (3) (2024)
Han Zhang, Sanghoon Lee, Renee R Muthakana, Binfeng Lu, David N Boone, Daniel Lee, Xiao-Song Wang
Intragenic Rearrangement Burden Associates with Immune Cell Infiltration and Response to Immune Checkpoint Blockade in Cancer. Cancer immunology research 12 (3) (2024)
Han Zhang, Sanghoon Lee, Renee R Muthakana, Binfeng Lu, David N Boone, Daniel Lee, Xiao-Song Wang
Intragenic Rearrangement Burden Associates with Immune Cell Infiltration and Response to Immune Checkpoint Blockade in Cancer. Cancer immunology research (2024)
Han Zhang, Sanghoon Lee, Renee R Muthakana, Binfeng Lu, David N Boone, Daniel Lee, Xiao-Song Wang
Intragenic Rearrangement Burden Associates with Immune Cell Infiltration and Response to Immune Checkpoint Blockade in Cancer. Cancer immunology research 12 (3) (2024)
Han Zhang, Sanghoon Lee, Renee R Muthakana, Binfeng Lu, David N Boone, Daniel Lee, Xiao-Song Wang
Intragenic Rearrangement Burden Associates with Immune Cell Infiltration and Response to Immune Checkpoint Blockade in Cancer. Cancer immunology research 12 (3) (2024)
Shaoxian Wu, Hao Huang, Runzi Sun, David Shihong Gao, Fan Ye, Jianing Huang, Ella Li, Andrew Ni, Kevin GuoKai Lu, Kong Chen, Jing Ting Jiang, Penelope A Morel, Ziyang Zhong, Binfeng Lu
Synergism Between IL21 and Anti-PD-1 Combination Therapy is Underpinned by the Coordinated Reprogramming of the Immune Cellular Network in the Tumor Microenvironment. Cancer research communications 3 (8) (2023)